IFNγ signaling in cytotoxic T cells restricts anti-tumor responses by inhibiting the maintenance and diversity of intra-tumoral stem-like T cells
2023 · Nature Communications · 69 citations
https://doi.org/10.1038/s41467-023-35948-9
O
Orion Tong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.1K
Citations
13
h-index
13
i10-index
Orion Tong is an academic researcher from University of Oxford. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 13, co-authored 37 publications.
ORCID: 0000-0002-0659-5944Papers by this author
worksIL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
2022 · Nature Medicine · 68 citations
https://doi.org/10.1038/s41591-022-02095-5
Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity
2022 · Nature Communications · 30 citations
https://doi.org/10.1038/s41467-022-31626-4
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade
2025 · Nature Medicine · 16 citations
https://doi.org/10.1038/s41591-025-03647-1
Characterization of the genetic determinants of context-specific DNA methylation in primary monocytes
2024 · Cell Genomics · 4 citations
https://doi.org/10.1016/j.xgen.2024.100541
1038P Interactions of immune checkpoint blockade and regulatory T cells
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.1096
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat